Eva Privitera is an analyst on the Healthcare team at Columbia Threadneedle Investments. In this role, she covers the biotechnology sector. She joined the firm in 2024 and has been a member of the investment community since 2021. Previously, Eva worked as an equity research vice president for three years at TD Cowen, where she covered SMID and Large Cap biotech stocks. Before that, she worked as an associate scientist for three years at a discovery stage biotech company, where she was responsible for early-stage drug screening and assay development. Eva earned an A.B. in Biology from Harvard College, a Ph.D. in Neuroscience from Mount Sinai School of Medicine, and a M.M. from the New England Conservatory of Music. In addition, she holds FINRA Series SIE, 63, 86, and 87 registrations.